Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility (English, HTML)
Draft guidance on management of rolling reviews for drug submissions: Rolling review process, eligibility: English HTML file. From Health Canada, updated Sep 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-09-01
Health Canada is offering an option for a rolling review of a new drug submission (NDS) or supplement to a new drug submission (SNDS) that meets specific eligibility conditions. Sponsors nearing the end of clinical development of a drug can apply to Health Canada for rolling review status for a forthcoming drug submission.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file